Laboratory for Clinical and Experimental Research on Vascular Biology, Biomedical Center, State University of Rio de Janeiro, RJ, Brazil.
Clinics (Sao Paulo). 2012 Aug;67(8):923-9. doi: 10.6061/clinics/2012(08)12.
Ischemic preconditioning and some drugs can protect tissues from injury by preserving microcirculation. This study evaluated vascular permeability in a hamster cheek pouch preparation using either short ischemic periods or bradykinin as preconditioning stimuli followed by 30 min of ischemia/reperfusion.
Sixty-six male hamsters were divided into 11 groups: five combinations of different ischemic frequencies and durations (one, three or five shorts periods of ischemia, separated by one or five minutes) with 10 min intervals between the ischemic periods, followed by 30 min ischemia/reperfusion; three or five 1 min ischemic periods with 10 min intervals between them followed by the topical application of histamine (2 µM); bradykinin (400 nM) followed by 30 min of ischemia/reperfusion; and three control groups (30 min of ischemia/reperfusion or histamine or bradykinin by themselves). Macromolecular permeability was assessed by injection of fluorescein-labeled dextran (FITC-dextran, MW= 150 kDa; 250 mg/Kg body weight), and the number of leaks/cm2 was counted using an intravital microscope and fluorescent light in the cheek pouch.
Plasma leakage (number of leaks/cm²) was significantly reduced by preconditioning with three and five 1 min ischemic periods, one and three 5 min ischemic periods and by bradykinin. Histamine-induced macromolecular permeability was also reduced after three periods of 5 min of ischemia.
Short ischemic periods and bradykinin can function as preconditioning stimuli of the ischemia/reperfusion response in the hamster cheek pouch microcirculation. Short ischemic periods also reduced histamineinduced macromolecular permeability.
缺血预处理和一些药物可以通过保护微循环来保护组织免受损伤。本研究通过使用短暂的缺血期或缓激肽作为预处理刺激物,评估了仓鼠颊囊制剂中的血管通透性,随后进行 30 分钟的缺血/再灌注。
将 66 只雄性仓鼠分为 11 组:5 种不同的缺血频率和持续时间的组合(一次、三次或五次短暂的缺血期,间隔 1 或 5 分钟),每个缺血期之间有 10 分钟的间隔,随后进行 30 分钟的缺血/再灌注;三次或五次 1 分钟的缺血期,间隔 10 分钟,然后局部应用组胺(2 µM);缓激肽(400 nM),随后进行 30 分钟的缺血/再灌注;以及三个对照组(单独进行 30 分钟的缺血/再灌注或组胺或缓激肽)。通过注射荧光标记的葡聚糖(FITC-dextran,MW=150 kDa;250 mg/Kg 体重)评估大分子通透性,并使用颊囊内的活体显微镜和荧光灯计数泄漏数/cm²。
三次和五次 1 分钟的缺血预处理、一次和三次 5 分钟的缺血预处理以及缓激肽均可显著减少血浆渗漏(泄漏数/cm²)。五次 5 分钟的缺血预处理后,组胺诱导的大分子通透性也降低了。
短暂的缺血期和缓激肽可以作为仓鼠颊囊微循环缺血/再灌注反应的预处理刺激物。短暂的缺血期也降低了组胺诱导的大分子通透性。